| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/17/1998 | EP0635003B1 Perhydroisoindole derivatives as p substance antagonists |
| 06/17/1998 | EP0500745B1 Metal-peptide compositions and cosmetic methods for stimulating hair growth |
| 06/17/1998 | EP0448704B1 Osteogenic devices |
| 06/17/1998 | CN1185112A Use of flavanolignanes for the prepn. of medicametns with antiproliferative activity in uterus, ovary and breast |
| 06/17/1998 | CN1185110A Synergistic combination of zidovudine |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/17/1998 | CN1184672A Hair-care medicine able to make hair blacker |
| 06/17/1998 | CN1038749C Method for prepn. of dibenz £b, f| £1, 4| oxazepin -11 (10H)-ones |
| 06/17/1998 | CN1038748C Method for prepn. of sulfonamide fibrinogen receptor antagonists |
| 06/16/1998 | US5767373 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/16/1998 | US5767274 Treating tumors or restenosis |
| 06/16/1998 | US5767268 Treatment of disorders characterized by excessive or destructive proliferation of smooth muscle cells |
| 06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
| 06/16/1998 | US5767160 Method and formulation of stimulating nitric oxide synthesis |
| 06/16/1998 | US5767159 Improving the capacity of muscles for work and shortening the time for recovery after exercise or various therapies, e.g.postoperative surgery, respiratory disorders |
| 06/16/1998 | US5767148 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carbonylbenzoic acid ethylene acetal and 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carboxylamidobenzoic acid having retinoid activityp; leukemia |
| 06/16/1998 | US5767134 Antitumor agents |
| 06/16/1998 | US5767133 Secondary amines as antidiabetic and antiobesity agents |
| 06/16/1998 | US5767126 Alzheimer's disease treatment with tacrine metabolites |
| 06/16/1998 | US5767120 Antiinflammatory agents, antiallergens; treatment for septic shock |
| 06/16/1998 | US5767119 Method of treating neurodegenerative diseases using an AMPA excitatory amino and an uricosuric agent |
| 06/16/1998 | US5767118 4-Heterocyclic peperidines promote release of growth hormone |
| 06/16/1998 | US5767117 Method for treating vascular headaches |
| 06/16/1998 | US5767116 Bicyclic aromatic compounds as therapeutic agents |
| 06/16/1998 | US5767111 18-nor-vitamin D compounds |
| 06/16/1998 | US5767110 Combination chemotherapy |
| 06/16/1998 | US5767094 Hypoglycemic agents |
| 06/16/1998 | US5767085 Peptide derivatives |
| 06/16/1998 | US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine |
| 06/16/1998 | US5766923 Isolated nucleic acid encoding ligands for FGFR |
| 06/16/1998 | US5766917 Method for identifying and producing a protease capable of cleaving the TNF receptor |
| 06/16/1998 | US5766877 Genes encoding art, an agouti-related transcript |
| 06/16/1998 | US5766863 Kinase receptor activation assay |
| 06/16/1998 | US5766593 Anti-inflammatory CD14 peptides |
| 06/16/1998 | US5766585 Infecting bone marrow cells with recombinant retroviral expression vector that contains a polynucleotide sequence coding a biologically active interleukin receptor antagonist protein, injecting into host; antiinflammatory agents |
| 06/16/1998 | US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol |
| 06/16/1998 | US5766571 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids |
| 06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
| 06/16/1998 | CA2224885A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them |
| 06/16/1998 | CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 06/16/1998 | CA2162470C Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as the active substance |
| 06/16/1998 | CA2065965C Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist |
| 06/16/1998 | CA2040374C Process for enhancing the resistance of aquatic animals to disease |
| 06/16/1998 | CA2003718C Compounds |
| 06/11/1998 | WO1998025142A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | WO1998024810A2 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | WO1998024809A1 Peptides agonists of bradykinine b2 receptor |
| 06/11/1998 | WO1998024806A2 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors |
| 06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024804A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024797A1 Antisense inhibition of human adhesion molecules |
| 06/11/1998 | WO1998024793A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
| 06/11/1998 | WO1998024791A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 06/11/1998 | WO1998024790A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 06/11/1998 | WO1998024788A1 Tropane derivatives and method for their synthesis |
| 06/11/1998 | WO1998024785A1 Indole-urea derivatives with 5-ht antagonist properties |
| 06/11/1998 | WO1998024784A1 Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
| 06/11/1998 | WO1998024783A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 06/11/1998 | WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 06/11/1998 | WO1998024763A2 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
| 06/11/1998 | WO1998024759A1 Metalloproteinase inhibitors |
| 06/11/1998 | WO1998024478A2 Tumour therapy |
| 06/11/1998 | WO1998024477A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 06/11/1998 | WO1998024467A1 Remedies for fulminant hepatitis |
| 06/11/1998 | WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 06/11/1998 | WO1998024461A1 Peptide synthesis with sulfonyl protecting groups |
| 06/11/1998 | WO1998024446A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 06/11/1998 | WO1998024445A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 06/11/1998 | WO1998024441A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 06/11/1998 | WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
| 06/11/1998 | WO1998024434A1 Novel therapeutic application of a thienycyclohexylamine derivative |
| 06/11/1998 | WO1998024416A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes |
| 06/11/1998 | WO1998012910A3 Novel CREBa isoform |
| 06/11/1998 | CA2274250A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/11/1998 | CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/11/1998 | CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
| 06/11/1998 | CA2274023A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity |
| 06/11/1998 | CA2273857A1 Peptide synthesis with sulfonyl protecting groups |
| 06/11/1998 | CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 06/11/1998 | CA2273845A1 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 06/11/1998 | CA2273809A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 06/11/1998 | CA2273807A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 06/11/1998 | CA2273800A1 Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety |
| 06/11/1998 | CA2273497A1 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(ii) complexes |
| 06/11/1998 | CA2273218A1 Tumour therapy |
| 06/11/1998 | CA2273203A1 Antisense inhibition of human adhesion molecules |
| 06/11/1998 | CA2273190A1 Peptides agonists of bradykinine b2 receptor |
| 06/11/1998 | CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them |
| 06/11/1998 | CA2273002A1 Immunotherapeutic imides/amides as pde iv and tnf inhibitors |
| 06/11/1998 | CA2272548A1 Serine protease inhibitors |
| 06/11/1998 | CA2272330A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 06/11/1998 | CA2271072A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 06/11/1998 | CA2245699A1 Substituted sulfonic acid n-¬(aminoiminomethyl)phenylalkyl}-azaheterocyclamide compounds |
| 06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
| 06/10/1998 | EP0846694A1 Morphinan derivative and its pharmaceutical applications |
| 06/10/1998 | EP0846689A1 Benzimidazole compounds |
| 06/10/1998 | EP0846688A1 New imidazoline derivatives having affinity for the imidazoline receptor |